Research: ALIMI and co-workers,

Listed in Issue 98

Abstract

ALIMI and co-workers, Pain Management Unit, INSERM, U521, Villejuif, France, have conducted a randomized, single-blinded controlled trial of auricular acupuncture for cancer pain.

Background

Auricular acupuncture has been used for 30 years as a complementary treatment for cancer pain when analgesic medication is not sufficient. This trial aimed to assess the analgesic effect of this acupuncture.

Methodology

90 patients were randomly divided into 3 groups. One group received two treatments of auricular acupuncture at points where an electrodermal signal had been detected. The second group received auricular acupuncture at points where no such signal had been detected (placebo points). The third group received auricular seeds fixed at placebo points. Patients had to be in pain with a score of at least 30 mm on a 100-mm pain VAS after analgesic medication for at least one month.

Results

The main outcome measure was pain intensity two months after treatment. Pain intensity decreased by 36% from baseline in the treatment group, compared to 2% in the two placebo groups (p < 0.0001).

Conclusion

The observed reduction in pain at two months post treatment represents a clear benefit of this analgesic therapy for cancer patients.

References

Alimi D, Rubino C, Pichard-Leandri E, Fermand-Brule S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. Journal of Clinical Oncology 21 (22): 4120-4126, Nov 2003.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page